Table of Advanced Disease-modifying Drug (DMD) Candidates
| Target/Approach | Notes (Theoretical) | Candidate Name | Trial Phase | Trial Start Date | Expected End Date | Planned Enrollment | AD population targeted (severity) | AD population targeted (genetic) | Comments |
|---|---|---|---|---|---|---|---|---|---|
| Gamma Secretase Modulator/NSAID | Shifts A-Beta production to shorter and less toxic species | MPC-7869 | Phase III | Feb 2005 | May 2008 | 1,600 | Mild | n/a | 800-patient Trial also underway worldwide. |
| Gamma Secretase Inhibitor | Inhibits Gamma Secretase, believed crucial to pathology | LY451039 | Phase III | March 2008 | March 2012 | 1,500 | Mild-to-Moderate | n/a | smaller trial completed '07, data not out. |
| Antibody to Amyloid-Beta | Mimics Natural Antibody triggered by AN-1792 | aab-001 | Phase III | Dec 2007 | Dec 2010 | 800 | Mild-to-Moderate | Apolipoprotein E4 Carriers only | Identical Trial also underway in Europe |
| Antibody to Amyloid-Beta | Mimics Natural Antibody triggered by AN-1792 | aab-001 | Phase III | Dec 2007 | Dec 2010 | 1,250 | Mild-to-Moderate | Apolipoprotein E4 Non-Carriers only | Identical Trial also underway in Europe |
| Metal-Protein Interaction Attenuation | Primary Targets Copper & Zinc | PBT2 | Phase II (completed) | Dec 2006 | Dec 2007 | 80 | early Alzheimer's disease | n/a | Deemed a Success; Phase III to start |
| Fibrilization of Amyloid-Beta | Prevents/Reverses Fibrilization of A-Beta | AZD-103 | Phase II | Dec 2007 | May 2010 | 340 | Mild-to-Moderate | n/a | Phase I was success |
| Neuroprotection | Neuroprotective Peptide, intra-nasal | AL-108 | Phase II (completed) | Jan 2007 | Jan 2008 | 120 | Mild Cognitive Impairment | n/a | Deemed a Success; Phase III to start |
| Brain Cell Apoptosis Inhibitor | Blocks Mitochondrial Pores | Dimebon | Phase II (completed) | Sept 2006 | Nov 2007 (actual) | 183 | Mild-to-Moderate | n/a | Deemed a Success; Phase III completed but failed |
| Natural Antibodies to A-Beta | human plasma source limits supply | IVIg | Phase II (completed) | Feb 2006 | June 2007 | 24 | Mild-to-Moderate | n/a | Deemed a Success; Phase III to start |
| Vaccine to Amyloid-Beta | Injects modified A-Beta (active vaccine) | acc-001 | Phase II | Nov 2007 | Mar 2012 | 228 | Mild-to-Moderate | n/a | Sequel to famous AN-1792 Vaccine Trial |
| Notes | |||||||||
Read more about this topic: Alzheimer's Disease Clinical Research
Famous quotes containing the words table, advanced, drug and/or candidates:
“Will you greet your doom
As final; set him loaves and wine; knowing
The game is finished when he plays his ace,
And overturn the table and go into the next room?”
—Philip Larkin (1922–1986)
“Predatory capitalism created a complex industrial system and an advanced technology; it permitted a considerable extension of democratic practice and fostered certain liberal values, but within limits that are now being pressed and must be overcome. It is not a fit system for the mid- twentieth century.”
—Noam Chomsky (b. 1928)
“Upon entering my vein, the drug would start a warm edge that would surge along until the brain consumed it in a gentle explosion. It began in the back of the neck and rose rapidly until I felt such pleasure that the world sympathizing took on a soft, lofty appeal.”
—Gus Van Sant, U.S. screenwriter and director, and Dan Yost. Bob Hughes (Matt Dillon)
“The idea that you can merchandise candidates for high office like breakfast cereal—that you can gather votes like box tops—is, I think, the ultimate indignity to the democratic process.”
—Adlai Stevenson (1900–1965)